Patents by Inventor Philippe Bridonneau

Philippe Bridonneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders
    Patent number: 9827302
    Abstract: The invention relates to a chimeric protein comprising or consisting of, from N-terminal to C-terminal, (a) a N-terminal part of a Bordetella CyaA protein (b) a heterologous polypeptide comprising antigens originating from different HPVs, and (c) a C-terminal part of a Bordetella CyaA protein. The invention also relates to a polynucleotide encoding this chimeric protein. A composition comprising at least one chimeric protein(s) of the invention and the prophylactic and/or therapeutic uses of said composition are also part of the invention.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: November 28, 2017
    Assignee: GENTICEL
    Inventors: Yolande Misseri, Philippe Bridonneau, Anne Goubier
  • HPV/CYAA-BASED CHIMERIC PROTEINS AND THEIR USES IN THE INDUCTION OF IMMUNE RESPONSES AGAINST HPV INFECTION AND HPV-INDUCED DISORDERS
    Publication number: 20150250867
    Abstract: The invention relates to a chimeric protein comprising or consisting of, from N-terminal to C-terminal, (a) a N-terminal part of a Bordetella CyaA protein (b) a heterologous polypeptide comprising antigens originating from different HPVs, and (c) a C-terminal part of a Bordetella CyaA protein. The invention also relates to a polynucleotide encoding this chimeric protein. A composition comprising at least one chimeric protein(s) of the invention and the prophylactic and/or therapeutic uses of said composition are also part of the invention.
    Type: Application
    Filed: July 23, 2013
    Publication date: September 10, 2015
    Applicant: GENTICEL
    Inventors: Yolande Misseri, Philippe Bridonneau, Anne Goubier
  • High Affinity Nucleic Acid Ligands To Lectins
    Publication number: 20090118481
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands. This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Application
    Filed: June 4, 2008
    Publication date: May 7, 2009
    Applicant: GILEAD SCIENCES, INC.
    Inventors: David H. Parma, Brian Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Patent number: 7399752
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: July 15, 2008
    Assignee: Gilead Science, Inc.
    Inventors: David H. Parma, Brian Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Publication number: 20040072234
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands. This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Application
    Filed: November 10, 2003
    Publication date: April 15, 2004
    Inventors: David H. Parma, Brian Hicke, Philippe Bridonneau, Lary Gold
  • High affinity nucleic acid ligands to lectins
    Publication number: 20040043923
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Application
    Filed: April 7, 2003
    Publication date: March 4, 2004
    Applicant: GILEAD SCIENCES, INC.
    Inventors: David H. Parma, Brian Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Patent number: 6544959
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: April 8, 2003
    Assignee: Gilead Sciences, Inc.
    Inventors: David H Parma, Brian Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Publication number: 20030059769
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Application
    Filed: May 4, 2001
    Publication date: March 27, 2003
    Inventors: David H. Parma, Brian Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Patent number: 6280932
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Grant
    Filed: November 21, 1997
    Date of Patent: August 28, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: David H Parma, Brian Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Patent number: 6001988
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 14, 1999
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: David H. Parma, Brian J. Hicke, Philippe Bridonneau, Larry Gold
  • High affinity nucleic acid ligands to lectins
    Patent number: 5780228
    Abstract: This invention discloses high-affinity oligonucleotide ligands to lectins, specifically nucleic acid ligands having the ability to bind to the lectins, wheat germ agglutinin, L-selectin, E-selectin and P-selectin. Also disclosed are the methods for obtaining such ligands.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 14, 1998
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: David H. Parma, Brian Hicke, Philippe Bridonneau, Larry Gold